AGA Clinical Practice Guidelines on the Medical Management of Moderate to Severe Luminal and Perianal Fistulizing Crohn’s Disease-Reference-Cited by-同舟云学术

AGA Clinical Practice Guidelines on the Medical Management of Moderate to Severe Luminal and Perianal Fistulizing Crohn’s Disease

Published:2021-06 Issue:7 Volume:160 Page:2496-2508
ISSN:0016-5085
Container-title:Gastroenterology
language:en
Short-container-title:Gastroenterology

Author:

Feuerstein Joseph D.,Ho Edith Y.,Shmidt Eugenia,Singh Harminder,Falck-Ytter Yngve,Sultan Shanaz,Terdiman Jonathan P.,Sultan Shahnaz,Cohen Benjamin L.,Chachu Karen,Day Lukejohn,Davitkov Perica,Lebwohl Benjamin,Levin Theodore R.,Patel Amit,Peery Anne F.,Shah Raj,Singh Harminder,Singh Siddharth,Spechler Stuart J.,Staller Kyle,Thrift Aaron P.,Weiss Jennifer M.

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference26 articles.

1. Crohn disease: epidemiology, diagnosis, and management;Feuerstein;Mayo Clin Proc,2017

2. Risk of surgery for inflammatory bowel diseases has decreased over time: a systematic review and meta-analysis of population-based studies;Frolkis;Gastroenterology,2013

3. Decreasing risk of first and subsequent surgeries in patients with Crohn's disease in England from 1994 through 2013;Burr;Clin Gastroenterol Hepatol,2019

4. Improvements in the long-term outcome of Crohn’s disease over the past two decades and the relation to changes in medical management: results from the population-based IBDSL cohort;Jeuring;Am J Gastroenterol,2017

5. Natural disease course of Crohn’s disease during the first 5 years after diagnosis in a European population-based inception cohort: an Epi-IBD study;Burisch;Gut,2019

Cited by 189 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Crohn’s Disease;Decision Making in Gastroenterology;2025

2. Comparative real-world outcomes between ustekinumab, infliximab, and adalimumab in bio-naïve and bio-experienced Crohn’s disease patients: a retrospective multicenter study;BMC Gastroenterology;2024-09-11

3. Risk of nonmelanoma skin cancer in patients taking Janus kinase inhibitors for inflammatory bowel disease: A systematic review and meta-analysis;Dermatologica Sinica;2024-09-04

4. Primary surgery versus pharmacotherapy for newly diagnosed ileocecal Crohn’s disease: a hospital-based cohort study;The Korean Journal of Internal Medicine;2024-09-01

5. Small Molecule Therapy for Inflammatory Bowel Disease: JAK Inhibitors and S1PR Modulators;The Korean Journal of Gastroenterology;2024-08-25